This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Case Studies in Cardiovascular Risk Reduction With Non-statin Therapies: Rapid-Fire Roundtable

Case Studies in Cardiovascular Risk Reduction With Non-statin Therapies: Rapid-Fire Roundtable

Format

Roundtable

Time to Complete

1 hour

Released

June 25, 2019

Expires

June 25, 2020
Add to Queue


Maximum Credits

1.00 / CNE Contact Hour

Accredited Provider

This continuing education activity is jointly provided by Vindico and Preventative Cardiovascular Nurses Association

Commercial Supporter

This activity is supported by an educational grant from Amgen.

Educational activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Program Description

Given the high prevalence of patients on statin therapy who do not reach low-density lipoprotein cholesterol target goals, continuing education is crucial regarding the use of non-statin therapies, such as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, to reduce cardiovascular (CV) risk. Clinicians, including CV nurses and CV nurse practitioners, play a critical role in the management of these patients in both assessing CV risk and ensuring proper use of PCSK9 inhibitors and other non-statin therapies. This educational activity will feature a Rapid-Fire Roundtable with experts who will review the latest data from CV outcomes studies, and clinical cases will be presented to highlight key educational objectives.

Intended Audience

The intended audience for this activity is cardiovascular nurses, cardiovascular nurse practitioners, and other health care professionals involved in the management of patients with dyslipidemia.

Purpose/Educational Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Review the latest clinical evidence regarding the impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and very low low-density lipoprotein cholesterol on cardiovascular outcomes.
  • Utilize PCSK9 inhibitors in patients who may benefit in accordance with the latest clinical evidence and recommendations.

Conflict Of Interest Disclosure Policy

In accordance with the American Nurses Credentialing Commission’s Standards for Commercial Support, all CE providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CE activity content over which the individual has control. Relationship information appears below.

Faculty

Joyce L. Ross, MSN, CRNP, FNLA, FPCNA
Diplomate Accreditation Council for Clinical Lipidology, Certified Clinical Lipid Specialist
Past President NLA, Past President PCNA

Ms. Ross discloses the following:
Consulting Fee: Amgen, Esperion, Sanofi/Regeneron
Speakers Bureau: Amarin, Amgen, Kowa, Novo Nordisk, Regeneron, Sanofi

Lynne Braun PhD, CNP, FAHA, FAANP, FPCNA, FAAN
Professor, Department of Internal Medicine
Professor, Department of Adult Health and Gerontological Nursing, College of Nursing
Nurse Practitioner, Rush Heart Center for Women
Rush University
Chicago, IL

Dr. Braun discloses the following:
Royalty: UpToDate

Nurse Planner and Reviewer
Barbara A. Niedz, PhD, RN, CPHQ
has no relevant financial relationships to disclose.

Accredited Provider Disclosure

Vindico Medical Education and Preventative Cardiovascular Nurses Association Staff have no relevant financial relationships to disclose.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

Vindico Medical Education will provide 1.00 contact hours for nurses.

Disclosure of Unlabeled Use

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Disclaimer

The material presented at or in any Vindico Medical Education and Preventative Cardiovascular Nurses Association continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education and Preventative Cardiovascular Nurses Association. Neither Vindico Medical Education, Preventative Cardiovascular Nurses Association, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Instructions

To participate in this CE activity, you must read the objectives, answer the pretest questions, review the content, and complete the CE posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a CE certificate.

If you have CME Questions, please contact Vindico Medical Education at cme@vindicoCME.com.

Privacy Policy

Copyright

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Preventative Cardiovascular Nurses Association continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Preventative Cardiovascular Nurses Association. Neither Vindico Medical Education, Preventative Cardiovascular Nurses Association, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue